# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-014589
Filing Date
2022-04-14
Accepted
2022-04-14 16:18:58
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | ny20002052x2_defa14a.htm | DEFA14A | 19566
2 |  | ny20002052x2-nc_1.jpg | GRAPHIC | 1385782
3 |  | ny20002052x2-nc_2.jpg | GRAPHIC | 1661884
| Complete submission text file | 0001140361-22-014589.txt |  | 4214476

Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 22827516
SIC: 2834 Pharmaceutical Preparations